Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.
Zelong HanMing LiuYuxin XieKunlin ZengZiling ZhanYanwen ChenLi WangXiaoxia ChenYaxin LuoYu ZengHongchao ZhanYingzhuo LinKeqin ZhangXiaoxia ZhuSi-de LiuXiao-Bei LuoAidong ZhouPublished in: Cell death discovery (2022)
Overproduction of reactive oxygen species (ROS) and aberrant lipid metabolism are established hallmarks of cancer; however, the role of ROS in lipid synthesis during tumorigenesis is almost unknown. Herein, we show that ROS regulates lipid synthesis and thus controls colorectal tumorigenesis through a p53-dependent mechanism. In p53 wild-type colorectal cancer (CRC) cells, hydrogen peroxide (H 2 O 2 )-induced p53 expression represses the transcription of deubiquitinase USP22, which otherwise deubiquitinates and stabilizes Fatty Acid Synthase (FASN), and thus inhibits fatty acid synthesis. Whereas, in p53-deficient CRC cells, ROS-mediated inhibition of USP22 is relieved, leading to FASN stabilization, which thus promotes lipid synthesis and tumor growth. In human CRC specimens, USP22 expression is positively correlated with FASN expression. Our study demonstrates that ROS critically regulates lipid synthesis and tumorigenesis through the USP22-FASN axis in a p53-dependent manner, and targeting the USP22-FASN axis may represent a potential strategy for the treatment of colorectal cancer.
Keyphrases
- fatty acid
- reactive oxygen species
- dna damage
- cell death
- hydrogen peroxide
- poor prognosis
- induced apoptosis
- oxidative stress
- cell cycle arrest
- wild type
- nitric oxide
- long non coding rna
- endothelial cells
- diabetic rats
- squamous cell carcinoma
- signaling pathway
- binding protein
- type diabetes
- metabolic syndrome
- young adults
- papillary thyroid
- drug delivery
- insulin resistance
- risk assessment
- high glucose
- combination therapy
- fine needle aspiration